Alveo

Founded in 1991, Alveo (formerly Asset Control) was one of the early entrants to the third-party Enterprise Data Management market and has established a global position providing financial data management software to a range of large financial institutions. Headquartered in London, the company has offices in the US, Singapore and the Netherlands.

The management team was keen to accelerate the company's growth plans via a management buyout and began to look for a partner to support them with an ambitious technology investment strategy and commercial re-positioning. In Sovereign they found what they were looking for.

Appointed Chair, the former President of Capital Markets at SunGard Data Systems.

Accelerated organic growth of the business and repositioned the customer proposition and revenue model.

Strengthened executive management team with the appointments of a CTO and CFO.

Supported transformation to a cloud-based data management platform and rebranding as Alveo.

Our investment in the business was predicated on a number of industry trends which combined to encourage banks and other financial institutions to increasingly invest in data. This included pressure from regulators for greater transparency, an increasing reliance on third parties for specialist technology and more demand than ever from clients to unlock the value in the data they hold, both cost-effectively and at scale.

We worked closely with the management team, enabling significant investment to reposition and accelerate the growth of the business, culminating in its rebrand to Alveo in December 2020.

Alveo successfully launched a cloud-native product portfolio and developed a software proposition with the business user at its core. This was delivered through a market-leading Micro Services architecture embracing Open Source and Open Standards. To support its customers further, Alveo also implemented a managed services offering and latterly launched both Data as a Service (DaaS) and ESG solutions to address significant market demand.

Sovereign realised its investment in Alveo to funds managed by Symphony Technology Group.